Calderon, Gerardo
Gonzalez-Izundegui, Daniel
Shan, Kuangda L.
Garcia-Valencia, Oscar A.
Cifuentes, Lizeth http://orcid.org/0000-0001-7865-2947
Campos, Alejandro http://orcid.org/0000-0002-6294-8652
Collazo-Clavell, Maria L.
Shah, Meera
Hurley, Daniel L.
Abu Lebdeh, Haitham S.
Sharma, Mayank
Schmitz, Kristine
Clark, Matthew M.
Grothe, Karen
Mundi, Manpreet S. http://orcid.org/0000-0001-7902-3544
Camilleri, Michael http://orcid.org/0000-0001-6472-7514
Abu Dayyeh, Barham K.
Hurtado Andrade, Maria D. http://orcid.org/0000-0002-2322-7334
Mokadem, Mohamad A.
Acosta, Andres http://orcid.org/0000-0003-2286-489X
Article History
Received: 26 May 2021
Revised: 30 September 2021
Accepted: 1 November 2021
First Online: 22 November 2021
Competing interests
: MSM has research grants from Fresenius Kabi, Nestle, Realfood Blends, and VectivBio and is a consultant for Baxter. AA reports other from Gila Therapeutics, other from Phenomix Sciences, personal fees from Rhythm Pharmaceuticals, personal fees from General Mills, outside the submitted work. BAD has served as a consultant for Boston Scientific, Metamodix, BFKW, DyaMx, and USGI Medical, has received research support for Boston Scientific, Apollo Endosurgery, USGI, Spatz Medical, GI Dynamics, Caim Diagnostics, Aspire Bariatrics, and Medtronic, and has been a speaker for Johnson & Johnson, Endogastric Solutions, and Olympus. MC is a stockholder in Phenomix Sciences and Enterin and serves as a consultant to Takeda, Allergan, Rhythm, Kallyope, and Arena with compensation to his employer, Mayo Clinic. Other authors declare no conflict of interest.